Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page adds related topics for Prostate cancer and MedlinePlus Genetics. This expands navigation to consumer health resources related to the study.
    Difference
    0.2%
    Check dated 2026-08-01T14:10:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, representing a minor update to the page’s version. No substantive study content is reflected in this change.
    Difference
    0.1%
    Check dated 2026-07-25T08:26:51.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Related topics metadata has been updated by removing 'Prostate cancer' and 'MedlinePlus Genetics' as related topics, and the related topics header has been removed. This reflects a downsizing of topic tagging around the study without changing the study content.
    Difference
    0.2%
    Check dated 2026-07-18T03:49:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The related topics section now includes Prostate cancer and MedlinePlus Genetics, linking to educational resources.
    Difference
    0.2%
    Check dated 2026-07-10T23:51:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor site update to the page template or backend without altering the study content.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the page's content or system without changing the study information.
    Difference
    0.1%
    Check dated 2026-06-27T00:10:12.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.